TECAN GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 302.6 CHF | +0.46% |
|
-1.50% | -11.88% |
| 06-24 | Tecan Appoints Mukta Acharya as Head of the Life Sciences Business Division, Effective from August 1, 2024 | CI |
| 04-18 | Tecan Group Approves Dividend, Payable on April 24, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,227 | 5,187 | 7,042 | 5,250 | 4,390 | 3,862 | - | - |
| Enterprise Value (EV) 1 | 2,911 | 4,716 | 7,051 | 5,138 | 4,257 | 3,687 | 3,583 | 3,463 |
| P/E ratio | 44 x | 50.3 x | 55.8 x | 43.5 x | 33.3 x | 31 x | 26.5 x | 23.6 x |
| Yield | 0.81% | 0.53% | 0.5% | 0.7% | 0.87% | 1.01% | 1.06% | 1.14% |
| Capitalization / Revenue | 5.07 x | 7.1 x | 7.44 x | 4.59 x | 4.09 x | 3.57 x | 3.32 x | 3.09 x |
| EV / Revenue | 4.57 x | 6.45 x | 7.45 x | 4.49 x | 3.96 x | 3.41 x | 3.08 x | 2.77 x |
| EV / EBITDA | 23.7 x | 29.6 x | 34.5 x | 23.9 x | 20.5 x | 16.8 x | 14.7 x | 12.9 x |
| EV / FCF | 32.6 x | 28.2 x | 54.2 x | 48.8 x | 33.9 x | 24.4 x | 23.9 x | 20.9 x |
| FCF Yield | 3.07% | 3.54% | 1.85% | 2.05% | 2.95% | 4.09% | 4.19% | 4.79% |
| Price to Book | 4.9 x | 7.07 x | 5.75 x | 3.87 x | 3.25 x | 2.69 x | 2.51 x | 2.33 x |
| Nbr of stocks (in thousands) | 11,866 | 11,957 | 12,677 | 12,730 | 12,783 | 12,822 | - | - |
| Reference price 2 | 272.0 | 433.8 | 555.5 | 412.4 | 343.4 | 301.2 | 301.2 | 301.2 |
| Announcement Date | 3/17/20 | 3/16/21 | 3/15/22 | 3/14/23 | 3/12/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 636.8 | 730.9 | 946.6 | 1,144 | 1,074 | 1,082 | 1,163 | 1,251 |
| EBITDA 1 | 122.8 | 159.1 | 204.6 | 214.9 | 207.3 | 219 | 243.9 | 268.9 |
| EBIT 1 | 98.7 | 121.4 | 145.5 | 147.8 | 136 | 149.9 | 172.4 | 194.4 |
| Operating Margin | 15.5% | 16.61% | 15.37% | 12.92% | 12.66% | 13.85% | 14.82% | 15.53% |
| Earnings before Tax (EBT) 1 | 82.74 | 118.2 | 137.9 | 142.5 | 133.8 | 146.5 | 170.4 | 193.4 |
| Net income 1 | 73.2 | 103.7 | 121.7 | 121.1 | 132.1 | 124.6 | 145 | 163.3 |
| Net margin | 11.49% | 14.19% | 12.86% | 10.59% | 12.29% | 11.51% | 12.47% | 13.05% |
| EPS 2 | 6.180 | 8.620 | 9.950 | 9.470 | 10.30 | 9.716 | 11.38 | 12.74 |
| Free Cash Flow 1 | 89.4 | 167 | 130.1 | 105.2 | 125.6 | 151 | 150.2 | 166 |
| FCF margin | 14.04% | 22.86% | 13.75% | 9.19% | 11.69% | 13.95% | 12.92% | 13.27% |
| FCF Conversion (EBITDA) | 72.8% | 104.99% | 63.61% | 48.96% | 60.6% | 68.94% | 61.59% | 61.75% |
| FCF Conversion (Net income) | 122.13% | 161.11% | 106.93% | 86.86% | 95.12% | 121.17% | 103.6% | 101.7% |
| Dividend per Share 2 | 2.200 | 2.300 | 2.800 | 2.900 | 3.000 | 3.034 | 3.184 | 3.429 |
| Announcement Date | 3/17/20 | 3/16/21 | 3/15/22 | 3/14/23 | 3/12/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 310 | 420.9 | 454 | 492.6 | 584 | 560.3 | 541.5 | - |
| EBITDA 1 | - | 98.94 | 115 | 89.56 | 119.1 | 95.8 | 101.2 | 111.1 |
| EBIT | 42.62 | 78.77 | - | 47.72 | - | 67.66 | - | - |
| Operating Margin | 13.75% | 18.71% | - | 9.69% | - | 12.07% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 62.68 | 71.12 |
| Net income 1 | - | 67.65 | - | 39.1 | 65.7 | 55.47 | 53.2 | 78.88 |
| Net margin | - | 16.07% | - | 7.94% | 11.25% | 9.9% | 9.82% | - |
| EPS | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 8/13/20 | 3/16/21 | 8/18/21 | 3/15/22 | 8/17/22 | 3/14/23 | 8/15/23 | 3/12/24 |
1CHF in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 9.2 | - | - | - | - | - |
| Net Cash position 1 | 317 | 471 | - | 111 | 133 | 175 | 279 | 399 |
| Leverage (Debt/EBITDA) | - | - | 0.045 x | - | - | - | - | - |
| Free Cash Flow 1 | 89.4 | 167 | 130 | 105 | 126 | 151 | 150 | 166 |
| ROE (net income / shareholders' equity) | 12.9% | 14.9% | 12.4% | 12% | 12.2% | 9.41% | 10.1% | 10.4% |
| ROA (Net income/ Total Assets) | - | - | - | - | 6.3% | 5.95% | 7.12% | 8.09% |
| Assets 1 | - | - | - | - | 2,095 | 2,093 | 2,036 | 2,019 |
| Book Value Per Share 2 | 55.50 | 61.30 | 96.60 | 107.0 | 106.0 | 112.0 | 120.0 | 129.0 |
| Cash Flow per Share 2 | 8.280 | 17.30 | 13.80 | 10.60 | 12.60 | 15.00 | 15.30 | 17.00 |
| Capex 1 | 23.9 | 41.3 | 39.7 | 36.2 | 34.9 | 24.9 | 27.1 | 29.2 |
| Capex / Sales | 3.76% | 5.65% | 4.2% | 3.17% | 3.25% | 2.3% | 2.33% | 2.34% |
| Announcement Date | 3/17/20 | 3/16/21 | 3/15/22 | 3/14/23 | 3/12/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
301.2
CHF
Average target price
396.6
CHF
Spread / Average Target
+31.66%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.88% | 4.32B | |
| +2.11% | 7.42B | |
| +0.16% | 3.15B | |
| +11.71% | 2.16B | |
| +14.67% | 1.09B | |
| -35.95% | 958M | |
| +7.20% | 927M | |
| -54.85% | 682M | |
| -35.14% | 632M | |
| -27.54% | 624M |
- Stock Market
- Equities
- TECN Stock
- Financials Tecan Group AG
